Access the full text.
Sign up today, get DeepDyve free for 14 days.
Mark Peifer, Li Pai, Michael Casey (1994)
Phosphorylation of the Drosophila adherens junction protein Armadillo: roles for wingless signal and zeste-white 3 kinase.Developmental biology, 166 2
U. Gat, R. Dasgupta, L. Degenstein, E. Fuchs (1998)
De Novo Hair Follicle Morphogenesis and Hair Tumors in Mice Expressing a Truncated β-Catenin in SkinCell, 95
Zhijian Chen, L. Parent, T. Maniatis (1996)
Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase ActivityCell, 84
R. Zurawel, S. Chiappa, C. Allen, C. Raffel (1998)
Sporadic Medulloblastomas Contain Oncogenic β-Catenin MutationsCancer Research, 58
M. Wong, B. Rubinfeld, J. Gordon (1998)
Effects of Forced Expression of an NH2-terminal Truncated β-Catenin on Mouse Intestinal Epithelial HomeostasisThe Journal of Cell Biology, 141
S. Munemitsu, I. Albert, B. Rubinfeld, P. Polakis (1996)
Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor proteinMolecular and Cellular Biology, 16
K. Willert, R. Nusse (1998)
Beta-catenin: a key mediator of Wnt signaling.Current opinion in genetics & development, 8 1
(1996)
Deletion of an amino-terminal sequence stabilizes �-catenin in vivo and promotes hyperphosphorylation of the adenomatous polyposis coli tumor suppressor protein
A. Barth, I. Näthke, W. Nelson (1997)
Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways.Current opinion in cell biology, 9 5
H. Aberle, A. Bauer, J. Stappert, A. Kispert, R. Kemler (1997)
β‐catenin is a target for the ubiquitin–proteasome pathwayThe EMBO Journal, 16
C. Yost, M. Torres, Jeffrey Miller, Eugene Huang, D. Kimelman, R. Moon (1996)
The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3.Genes & development, 10 12
M. Bienz (1998)
TCF: transcriptional activator or repressor?Current opinion in cell biology, 10 3
Y. Miyoshi, K. Iwao, Y. Nagasawa, T. Aihara, Y. Sasaki, S. Imaoka, M. Murata, T. Shimano, Y. Nakamura (1998)
Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3.Cancer research, 58 12
T. He, A. Sparks, C. Rago, H. Hermeking, L. Zawel, L. Costa, P. Morin, B. Vogelstein, K. Kinzler (1998)
Identification of c-MYC as a target of the APC pathway.Science, 281 5382
B. Rubinfeld, P. Robbins, M. El-Gamil, I. Albert, E. Porfiri, P. Polakis (1997)
Stabilization of β-Catenin by Genetic Defects in Melanoma Cell LinesScience, 275
R. Pujol, J. Casanova, R. Egido, J. Pujol, J. Moragas (1995)
Multiple Familial Pilomatricomas: A Cutaneous Marker for Gardner Syndrome?Pediatric Dermatology, 12
H. Voeller, C. Truica, E. Gelmann (1998)
β-Catenin Mutations in Human Prostate CancerCancer Research, 58
Pengbo Zhou, C. Byrne, J. Jacobs, E. Fuchs (1995)
Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate.Genes & development, 9 6
T. Fukuchi, M. Sakamoto, H. Tsuda, K. Maruyama, S. Nozawa, S. Hirohashi (1998)
Beta-catenin mutation in carcinoma of the uterine endometrium.Cancer research, 58 16
W. Foulkes (1995)
A tale of four syndromes: familial adenomatous polyposis, Gardner syndrome, attenuated APC and Turcot syndrome.QJM : monthly journal of the Association of Physicians, 88 12
J. Palacios, C. Gamallo (1998)
Mutations in the β-Catenin Gene (CTNNB1) in Endometrioid Ovarian CarcinomasCancer Research, 58
K. Cadigan, R. Nusse (1997)
Wnt signaling: a common theme in animal development.Genes & development, 11 24
K. Willert, R. Nusse (1998)
β-catenin: a key mediator of Wnt signalingCurrent Opinion in Genetics & Development, 8
C. Genderen, R. Okamura, I. Fariñas, R. Quo, T. Parslow, L. Bruhn, R. Grosschedl (1994)
Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice.Genes & development, 8 22
K. Orford, C. Crockett, J. Jensen, A. Weissman, S. Byers (1997)
Serine Phosphorylation-regulated Ubiquitination and Degradation of β-Catenin*The Journal of Biological Chemistry, 272
J. Behrens, J. Kries, M. Kühl, L. Bruhn, D. Wedlich, R. Grosschedl, W. Birchmeier (1996)
Functional interaction of β-catenin with the transcription factor LEF-1Nature, 382
P. Morin, A. Sparks, V. Kořínek, N. Barker, H. Clevers, B. Vogelstein, K. Kinzler (1997)
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APCScience, 275
Jeffrey Miller, R. Moon (1996)
Signal transduction through beta-catenin and specification of cell fate during embryogenesis.Genes & development, 10 20
A. Sparks, P. Morin, B. Vogelstein, K. Kinzler (1998)
Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal CancerCancer Research, 58
A. Coste, B. Romagnolo, P. Billuart, C. Renard, M. Buendia, O. Soubrane, M. Fabre, J. Chelly, C. Beldjord, Axel Kahn, C. Perret (1998)
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.Proceedings of the National Academy of Sciences of the United States of America, 95 15
K. Kinzler, B. Vogelstein (1996)
Lessons from Hereditary Colorectal CancerCell, 87
O. Müller, I. Nimmrich, U. Finke, W. Friedl, I. Hoffmann (1998)
A β‐catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of β‐catenin germline mutations in FAP patientsGenes, 22
WNT signalling orchestrates a number of developmental programs 1,2,3 . In response to this stimulus, cytoplasmic β-catenin (encoded by CTNNB1 ) is stabilized, enabling downstream transcriptional activation by members of the LEF/TCF family 4,5 . One of the target genes for β-catenin/TCF encodes c-MYC, explaining why constitutive activation of the WNT pathway can lead to cancer, particularly in the colon 6 . Most colon cancers arise from mutations in the gene encoding adenomatous polyposis coli (APC), a protein required for ubiquitin-mediated degradation of β-catenin 7 , but a small percentage of colon and some other cancers harbour β-catenin–stabilizing mutations (refs 8,9,10,11, 12,13,14,15,16, 17). Recently, we discovered that transgenic mice expressing an activated β-catenin are predisposed to developing skin tumours resembling pilomatricomas 18 . Given that the skin of these adult mice also exhibits signs of de novo hair-follicle morphogenesis, we wondered whether human pilomatricomas might originate from hair matrix cells and whether they might possess β-catenin–stabilizing mutations. Here, we explore the cell origin and aetiology of this common human skin tumour. We found nuclear LEF-1 in the dividing tumour cells, providing biochemical evidence that pilomatricomas are derived from hair matrix cells. At least 75% of these tumours possess mutations affecting the amino-terminal segment, normally involved in phosphorylation-dependent, ubiquitin-mediated degradation of the protein. This percentage of CTNNB1 mutations is greater than in all other human tumours examined thus far, and directly implicates β-catenin/LEF misregulation as the major cause of hair matrix cell tumorigenesis in humans.
Nature Genetics – Springer Journals
Published: Apr 1, 1999
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.